Article
Therapeutic modulation of the blood-brain barrier and ischemic stroke by a bioengineered FZD <sub>4</sub> -selective WNT surrogate
2022-10-14
Abstract excerpt
Derangements of the blood-brain barrier (BBB) or blood-retinal barrier (BRB) occur in disorders ranging from stroke, cancer, diabetic retinopathy, and Alzheimer’s disease. The Norrin/FZD 4 /TSPAN12 pathway activates WNT/β-catenin signaling, which is essential for BBB and BRB function. However, systemic pharmacologic FZD 4 stimulation is hindered by obligate palmitoylation and insolubility of native WNTs and subo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ed61e7d0-a333-5195-ad10-62f1ad9a8011
- DOI
- 10.1101/2022.10.13.510564
